Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 07-2022 | 04-2022 | 01-2022 | 10-2021 | 07-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,466 | 586 | 1,206 | 1,835 | 2,465 |
| Receivables | 201 | 198 | 206 | 238 | 368 |
| Inventories | 179 | 301 | 299 | 312 | 332 |
| TOTAL | $3,864 | $1,110 | $1,740 | $2,453 | $3,197 |
| Non-Current Assets | |||||
| PPE Net | 620 | 697 | 728 | 769 | 740 |
| Intangibles | 0 | 311 | 321 | 333 | 366 |
| TOTAL | $620 | $1,008 | $1,049 | $1,102 | $1,106 |
| Total Assets | $4,484 | $2,118 | $2,789 | $3,555 | $4,303 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 239 | 239 |
| Accounts payable and accrued liabilities | 488 | 416 | 425 | 465 | 593 |
| Accrued Expenses | 87 | 134 | 159 | 124 | 138 |
| TOTAL | $575 | $550 | $584 | $828 | $970 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $575 | $550 | $584 | $828 | $970 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 111,357 | 88,023 | 87,873 | 87,873 | 87,223 |
| Common Shares | 1,114 | 881 | 879 | 879 | 873 |
| Retained earnings | -129,284 | -128,051 | -127,291 | -126,589 | -125,793 |
| TOTAL | $3,909 | $1,568 | $2,205 | $2,727 | $3,333 |
| Total Liabilities And Equity | $4,484 | $2,118 | $2,789 | $3,555 | $4,303 |